KalVista Pharmaceuticals Ownership 2024 | Who Owns KalVista Pharmaceuticals Now?
Institutional Ownership
27.92%
Insider Ownership
1.44%
Retail Ownership
70.64%
Institutional Holders
61.00
KalVista Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VR ADVISER, LLC | 14.34% | 4.69% | 6,249,731 | - | - | 73,621,831 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 9.68% | 5.06% | 4,218,829 | 93,484 | 2.27% | 49,697,806 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.62% | 1.81% | 4,192,005 | - | - | 49,381,819 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 8.46% | 2.03% | 3,687,867 | - | - | 43,443,073 | Jun 30, 2024 |
| CAPITAL WORLD INVESTORS | 7.40% | 0.01% | 3,227,620 | 1,763,014 | 120.37% | 38,021,364 | Jun 30, 2024 |
| BLACKROCK INC. | 6.76% | 0.00% | 2,945,116 | 512,882 | 21.09% | 34,693,467 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 5.28% | 2.02% | 2,300,000 | 1,645,000 | 251.15% | 27,094,000 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.70% | 0.04% | 2,050,000 | -525,000 | -20.39% | 24,149,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.57% | 0.00% | 1,990,588 | 305,475 | 18.13% | 23,449,127 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 3.65% | 0.99% | 1,590,000 | - | - | 18,730,200 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 3.07% | 3.02% | 1,338,568 | 1,338,568 | 100.00% | 15,768,331 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 2.59% | 5.02% | 1,128,478 | -313,474 | -21.74% | 13,293,471 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 2.43% | 2.03% | 1,059,540 | -119,880 | -10.16% | 12,481,381 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 2.02% | 1.61% | 881,937 | 121,215 | 15.93% | 10,389,218 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 1.85% | 2.27% | 806,973 | - | - | 9,506,142 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.85% | 0.00% | 806,271 | 154,383 | 23.68% | 9,499,311 | Jun 30, 2024 |
| STATE STREET CORP | 1.74% | 0.00% | 756,430 | 162,257 | 27.31% | 8,910,745,000 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.69% | 2.55% | 736,765 | -424,295 | -36.54% | 8,679,092 | Jun 30, 2024 |
| EMERALD ADVISERS, LLC | 1.48% | 0.32% | 643,897 | -27,279 | -4.06% | 7,585,107 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.29% | 1.56% | 560,883 | -300 | -0.05% | 6,607,202 | Jun 30, 2024 |
KalVista Pharmaceuticals's largest institutional shareholder is VR ADVISER, LLC, holding 14.34% of the company's total share outstanding, currently valued at $73.62M. The top 10 institutional shareholders own together 74.45% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 9.68% | 5.06% | 4,218,829 | 93,484 | 2.27% | 49,697,806 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 2.59% | 5.02% | 1,128,478 | -313,474 | -21.74% | 13,293,471 | Jun 30, 2024 |
| VR ADVISER, LLC | 14.34% | 4.69% | 6,249,731 | - | - | 73,621,831 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 0.78% | 3.06% | 337,985 | 50,000 | 17.36% | 3,981,463 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 3.07% | 3.02% | 1,338,568 | 1,338,568 | 100.00% | 15,768,331 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.50% | 2.76% | 219,277 | - | - | 2,583,083 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.69% | 2.55% | 736,765 | -424,295 | -36.54% | 8,679,092 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 1.85% | 2.27% | 806,973 | - | - | 9,506,142 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 8.46% | 2.03% | 3,687,867 | - | - | 43,443,073 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 2.43% | 2.03% | 1,059,540 | -119,880 | -10.16% | 12,481,381 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 5.28% | 2.02% | 2,300,000 | 1,645,000 | 251.15% | 27,094,000 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.62% | 1.81% | 4,192,005 | - | - | 49,381,819 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 2.02% | 1.61% | 881,937 | 121,215 | 15.93% | 10,389,218 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.29% | 1.56% | 560,883 | -300 | -0.05% | 6,607,202 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 3.65% | 0.99% | 1,590,000 | - | - | 18,730,200 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.11% | 0.50% | 46,000 | - | - | 541,880 | Jun 30, 2024 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1.21% | 0.33% | 529,365 | - | - | 6,235,920 | Jun 30, 2024 |
| EMERALD ADVISERS, LLC | 1.48% | 0.32% | 643,897 | -27,279 | -4.06% | 7,585,107 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.09% | 0.24% | 39,593 | 39,593 | 100.00% | 466,406 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.42% | 0.23% | 184,358 | 1,714 | 0.94% | 2,171,737 | Jun 30, 2024 |
The largest KalVista Pharmaceuticals shareholder by % of total assets is TANG CAPITAL MANAGEMENT LLC. The company owns 4.22M shares of KalVista Pharmaceuticals (KALV), representing 5.06% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 7.40% | 0.01% | 3,227,620 | 1,763,014 | 120.37% | 38,021,364 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 5.28% | 2.02% | 2,300,000 | 1,645,000 | 251.15% | 27,094,000 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 3.07% | 3.02% | 1,338,568 | 1,338,568 | 100.00% | 15,768,331 | Jun 30, 2024 |
| BLACKROCK INC. | 6.76% | 0.00% | 2,945,116 | 512,882 | 21.09% | 34,693,467 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.57% | 0.00% | 1,990,588 | 305,475 | 18.13% | 23,449,127 | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1.07% | 0.01% | 467,998 | 213,224 | 83.69% | 5,513,016 | Jun 30, 2024 |
| STATE STREET CORP | 1.74% | 0.00% | 756,430 | 162,257 | 27.31% | 8,910,745,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.85% | 0.00% | 806,271 | 154,383 | 23.68% | 9,499,311 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.49% | 0.00% | 212,888 | 153,057 | 255.82% | 2,507,820 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.40% | 0.02% | 175,000 | 140,000 | 400.00% | 2,061,500 | Jun 30, 2024 |
| NORGES BANK | 0.30% | 0.00% | 131,300 | 131,300 | 100.00% | 1,546,714 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 2.02% | 1.61% | 881,937 | 121,215 | 15.93% | 10,389,218 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 9.68% | 5.06% | 4,218,829 | 93,484 | 2.27% | 49,697,806 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.18% | 0.00% | 78,682 | 78,682 | 100.00% | 926,873 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.16% | 0.02% | 68,526 | 52,347 | 323.55% | 807,236 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 0.78% | 3.06% | 337,985 | 50,000 | 17.36% | 3,981,463 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.28% | 0.09% | 122,960 | 40,960 | 49.95% | 1,448,469 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.09% | 0.24% | 39,593 | 39,593 | 100.00% | 466,406 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.14% | 0.00% | 62,507 | 38,552 | 160.94% | 736,332 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.25% | 0.00% | 110,594 | 32,456 | 41.54% | 1,302,797 | Jun 30, 2024 |
As of Jun 30 2024, KalVista Pharmaceuticals's largest institutional buyer is CAPITAL WORLD INVESTORS. The company purchased 1.76M stocks of KALV, valued at $38.02M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TCG CROSSOVER MANAGEMENT, LLC | - | - | - | -1,163,356 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.11% | 0.00% | 48,911 | -579,976 | -92.22% | 576,172 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.70% | 0.04% | 2,050,000 | -525,000 | -20.39% | 24,149,000 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.69% | 2.55% | 736,765 | -424,295 | -36.54% | 8,679,092 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -386,000 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -350,000 | -100.00% | - | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 2.59% | 5.02% | 1,128,478 | -313,474 | -21.74% | 13,293,471 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -243,484 | -100.00% | - | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -200,000 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.06% | 0.00% | 28,197 | -163,502 | -85.29% | 332,161 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.07% | 0.00% | 29,589 | -149,149 | -83.45% | 348,559 | Jun 30, 2024 |
| ALPHACENTRIC ADVISORS LLC | 0.01% | 0.02% | 2,500 | -127,500 | -98.08% | 29,450 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -120,308 | -100.00% | - | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 2.43% | 2.03% | 1,059,540 | -119,880 | -10.16% | 12,481,381 | Jun 30, 2024 |
| MORGAN STANLEY | 0.78% | 0.00% | 338,584 | -85,850 | -20.23% | 3,988,526 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.05% | - | 20,940 | -69,620 | -76.88% | 246,672 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.02% | 0.00% | 10,704 | -57,501 | -84.31% | 126,093 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -55,444 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | 0.05% | 0.02% | 19,901 | -45,104 | -69.39% | 234,434 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.23% | 0.00% | 534,979 | -44,680 | -7.71% | 6,302,535 | Jun 30, 2024 |
As of Jun 30 2024, KalVista Pharmaceuticals's biggest institutional seller is TCG CROSSOVER MANAGEMENT, LLC. The company sold -1.16M shares of KALV, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3.07% | 3.02% | 1,338,568 | 1,338,568 | 100.00% | 15,768,331 | Jun 30, 2024 |
| NORGES BANK | 0.30% | 0.00% | 131,300 | 131,300 | 100.00% | 1,546,714 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.18% | 0.00% | 78,682 | 78,682 | 100.00% | 926,873 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.09% | 0.24% | 39,593 | 39,593 | 100.00% | 466,406 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.05% | 0.00% | 21,380 | 21,380 | 100.00% | 251,857 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 20,489 | 20,489 | 100.00% | 241,360 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 16,270 | 16,270 | 100.00% | 191,661 | Jun 30, 2024 |
| EVOKE WEALTH, LLC | 0.04% | 0.21% | 15,373 | 15,373 | 100.00% | 181,088 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.03% | 0.00% | 15,113 | 15,113 | 100.00% | 178,031 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.01% | 2,100 | 2,100 | 100.00% | 24,738 | Jun 30, 2024 |
| 1620 INVESTMENT ADVISORS, INC. | 0.00% | 0.01% | 1,590 | 1,590 | 100.00% | 18,730 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 79 | 79 | 100.00% | 951 | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | 0.00% | - | 39 | 39 | 100.00% | 459 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 30 | 30 | 100.00% | 353 | Jun 30, 2024 |
| CREEKMUR ASSET MANAGEMENT LLC | 0.00% | 0.00% | 23 | 23 | 100.00% | 271 | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | 13 | 13 | 100.00% | 155 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 10 | 10 | 100.00% | 118 | Jun 30, 2024 |
KalVista Pharmaceuticals's largest new institutional shareholder by number of shares is GREAT POINT PARTNERS LLC, purchased 1.34M shares, valued at $15.77M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TCG CROSSOVER MANAGEMENT, LLC | - | - | - | -1,163,356 | -100.00% | - | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -386,000 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -350,000 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -243,484 | -100.00% | - | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -200,000 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -120,308 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -55,444 | -100.00% | - | Jun 30, 2024 |
| PDT PARTNERS, LLC | - | - | - | -41,951 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -32,025 | -100.00% | - | Jun 30, 2024 |
| LINCOLN NATIONAL CORP | - | - | - | -20,660 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -20,615 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -19,329 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -15,500 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -15,431 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -14,467 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -12,800 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -12,082 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -10,538 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -10,234 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -10,172 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -3,600 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,820 | -100.00% | - | Jun 30, 2024 |
| QUEST PARTNERS LLC | - | - | - | -1,800 | -100.00% | - | Jun 30, 2024 |
| QUARRY LP | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -414 | -100.00% | - | Jun 30, 2024 |
| QUADRANT CAPITAL GROUP LLC | - | - | - | -81 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -16 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
KalVista Pharmaceuticals's largest sold out institutional shareholder by shares sold is TCG CROSSOVER MANAGEMENT, LLC, sold -1.16M shares, valued at -, as of undefined.
KalVista Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HARTFORD HLS SERIES FUND II INC | 0.95% | 233,566 | - | - | Dec 31, 2023 |
| TEKLA HEALTHCARE INVESTORS | 0.08% | 68,406 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.07% | 614,300 | - | - | Jan 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.07% | 31,594 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.05% | 471,389 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 23,051 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.03% | 2,700 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.01% | 221 | - | - | Dec 31, 2023 |
| FORUM FUNDS II | 0.01% | 9,900 | 9,900 | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 29,701 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.01% | 11,784 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,696 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 69,153 | -431 | -0.62% | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 42,833 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 16,394 | - | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 30,644 | -10,615 | -25.73% | Aug 31, 2023 |
| BRIDGEWAY FUNDS INC | 0.00% | 10,500 | - | - | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,423,318 | -566,393 | -28.47% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 31,129 | - | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 114,507 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 487 | - | - | Mar 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 170,922 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 24,200 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 80,451 | 15,297 | 23.48% | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 4,321 | -26,656 | -86.05% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 21,855 | 169 | 0.78% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 144,583 | - | - | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 53,653 | - | - | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 15,805 | - | - | Dec 31, 2023 |
| SMALLCAP WORLD FUND INC | 0.00% | 108,104 | 108,104 | - | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 146,361 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 276,282 | 40,231 | 17.04% | Feb 29, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 7,424 | - | - | Mar 31, 2020 |
| FIDELITY COVINGTON TRUST | 0.00% | 23,968 | -276 | -1.14% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 81,600 | - | - | Feb 29, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 363,698 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 2,468 | - | - | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 127,383 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 23,274 | 5,398 | 30.20% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 15,202 | 159 | 1.06% | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 35,589 | -30,943 | -46.51% | Feb 29, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 7,601 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,622 | -1,017 | -13.31% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 517,881 | 153,731 | 42.22% | Jan 31, 2024 |
| RBB FUND, INC. | 0.00% | 39,035 | - | - | Feb 29, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 6,802 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 51,817 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 48,260 | -6,377 | -11.67% | Mar 28, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 10,290 | -2,249 | -17.94% | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 2,254 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 135,411 | -12,397 | -8.39% | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 32,609 | 7,683 | 30.82% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,379 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,051 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 59,353 | - | - | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 112 | - | - | Apr 30, 2021 |
| Global X Funds | 0.00% | 9,401 | - | - | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 700 | - | - | Mar 28, 2024 |
| HC CAPITAL TRUST | 0.00% | 5,243 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 10,300 | -3,000 | -22.56% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 3,078 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 390 | - | - | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 146,600 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 41,650 | 28,651 | 220.41% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 1,356,184 | -28,684 | -2.07% | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 6,392 | - | - | Jan 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 8,516 | - | - | Mar 28, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 7,030 | - | - | Mar 28, 2024 |
| EQ ADVISORS TRUST | 0.00% | 82,846 | -137 | -0.17% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 135,847 | 38,539 | 39.61% | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 7,577 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 225 | - | - | Dec 31, 2023 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 767 | - | - | Mar 31, 2024 |
| Series Portfolios Trust | 0.00% | 261 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 11,881 | 2,392 | 25.21% | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,004 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,796 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 130,000 | -7,000 | -5.11% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 7,642 | 4,459 | 140.09% | Feb 29, 2024 |
| Meeder Funds | 0.00% | 137 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 800 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 111 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,387 | 674 | 24.84% | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 7,512 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 2,800 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 130 | - | - | Feb 29, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 673 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 243 | -17 | -6.54% | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 65,211 | -19,584 | -23.10% | Mar 28, 2024 |
| PGIM ETF TRUST | 0.00% | 1,268 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 58,962 | 9,553 | 19.33% | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 156,741 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 5,034 | 1,939 | 62.65% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 530,513 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,371 | 500 | 57.41% | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 38,290 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 15 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,823 | -152 | -5.11% | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,067 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 10,671 | - | - | Mar 31, 2024 |
KalVista Pharmaceuticals's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 233.57K shares, compromising 0.95% of its total assets.
KalVista Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 61 | -53.79% |
| 31 Mar, 24 | 132 | 24.53% |
| 31 Dec, 23 | 106 | -4.50% |
| 30 Sep, 23 | 111 | 13.27% |
| 30 Jun, 23 | 98 | 10.11% |
| 31 Mar, 23 | 89 | -6.32% |
| 31 Dec, 22 | 95 | - |
| 30 Sep, 22 | 95 | 6.74% |
| 30 Jun, 22 | 89 | 1.14% |
| 31 Mar, 22 | 88 | -10.20% |
| 31 Dec, 21 | 98 | -10.91% |
| 30 Sep, 21 | 110 | -5.98% |
| 30 Jun, 21 | 117 | -4.88% |
| 31 Mar, 21 | 123 | 36.67% |
| 31 Dec, 20 | 90 | 47.54% |
| 30 Sep, 20 | 61 | -15.28% |
| 30 Jun, 20 | 72 | 5.88% |
| 31 Mar, 20 | 68 | -6.85% |
| 31 Dec, 19 | 73 | -3.95% |
| 30 Sep, 19 | 76 | 1.33% |
| 30 Jun, 19 | 75 | 10.29% |
| 31 Mar, 19 | 68 | 21.43% |
| 31 Dec, 18 | 56 | 19.15% |
| 30 Sep, 18 | 47 | 88.00% |
| 30 Jun, 18 | 25 | 8.70% |
| 31 Mar, 18 | 23 | 4.55% |
| 31 Dec, 17 | 22 | 46.67% |
| 30 Sep, 17 | 15 | -11.76% |
| 30 Jun, 17 | 17 | -5.56% |
| 31 Mar, 17 | 18 | -5.26% |
| 31 Dec, 16 | 19 | - |
As of 30 Jun 24, 61 institutions are holding KalVista Pharmaceuticals's shares, representing a decrease of -53.79% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 12,170,426 | -74.10% |
| 31 Mar, 24 | 46,987,795 | 27.12% |
| 31 Dec, 23 | 36,964,765 | 1.93% |
| 30 Sep, 23 | 36,263,336 | 5.26% |
| 30 Jun, 23 | 34,451,525 | 2.17% |
| 31 Mar, 23 | 33,720,527 | -2.54% |
| 31 Dec, 22 | 34,599,737 | 34.95% |
| 30 Sep, 22 | 25,639,626 | 5.70% |
| 30 Jun, 22 | 24,257,176 | -0.31% |
| 31 Mar, 22 | 24,333,766 | 2.29% |
| 31 Dec, 21 | 23,787,859 | 1.84% |
| 30 Sep, 21 | 23,357,229 | -3.84% |
| 30 Jun, 21 | 24,290,978 | 3.15% |
| 31 Mar, 21 | 23,548,120 | 43.71% |
| 31 Dec, 20 | 16,385,573 | 1.14% |
| 30 Sep, 20 | 16,200,853 | 1.34% |
| 30 Jun, 20 | 15,986,874 | 2.08% |
| 31 Mar, 20 | 15,660,534 | 14.13% |
| 31 Dec, 19 | 13,721,802 | 4.08% |
| 30 Sep, 19 | 13,183,718 | -10.84% |
| 30 Jun, 19 | 14,786,498 | 6.33% |
| 31 Mar, 19 | 13,905,907 | 4.44% |
| 31 Dec, 18 | 13,315,168 | 5.33% |
| 30 Sep, 18 | 12,641,824 | 100.14% |
| 30 Jun, 18 | 6,316,414 | -2.86% |
| 31 Mar, 18 | 6,502,235 | 0.28% |
| 31 Dec, 17 | 6,483,901 | -15.96% |
| 30 Sep, 17 | 7,715,149 | 4.70% |
| 30 Jun, 17 | 7,368,643 | -2.89% |
| 31 Mar, 17 | 7,587,600 | 3.49% |
| 31 Dec, 16 | 7,331,434 | - |
KalVista Pharmaceuticals (KALV) has 12.17M shares outstanding as of 30 Jun 24, down -74.10% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 27.92% | 0.24% |
| 31 Mar, 24 | 107.79% | 0.95% |
| 31 Dec, 23 | 106.45% | 0.97% |
| 30 Sep, 23 | 104.91% | 1.05% |
| 30 Jun, 23 | 100.11% | 1.04% |
| 31 Mar, 23 | 98.19% | 0.66% |
| 31 Dec, 22 | 122.35% | 1.13% |
| 30 Sep, 22 | 104.25% | 1.07% |
| 30 Jun, 22 | 98.78% | 1.00% |
| 31 Mar, 22 | 99.15% | 1.05% |
| 31 Dec, 21 | 97.17% | 1.06% |
| 30 Sep, 21 | 95.57% | 0.97% |
| 30 Jun, 21 | 99.43% | 0.65% |
| 31 Mar, 21 | 123.32% | 1.48% |
| 31 Dec, 20 | 91.22% | 1.11% |
| 30 Sep, 20 | 90.47% | 1.13% |
| 30 Jun, 20 | 89.57% | 1.16% |
| 31 Mar, 20 | 87.77% | 1.48% |
| 31 Dec, 19 | 76.92% | 1.41% |
| 30 Sep, 19 | 73.97% | 1.03% |
| 30 Jun, 19 | 84.55% | 1.29% |
| 31 Mar, 19 | 80.92% | 1.36% |
| 31 Dec, 18 | 77.27% | 1.10% |
| 30 Sep, 18 | 83.67% | 2.45% |
| 30 Jun, 18 | 58.49% | 1.47% |
| 31 Mar, 18 | 63.00% | 1.74% |
| 31 Dec, 17 | 60.10% | 1.01% |
| 30 Sep, 17 | 77.12% | 1.34% |
| 30 Jun, 17 | 75.86% | 1.24% |
| 31 Mar, 17 | 78.12% | 0.85% |
| 31 Dec, 16 | 95.74% | - |
As of 30 Jun 24, KalVista Pharmaceuticals is held by 27.92% institutional shareholders, representing a 0.24% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 36 | -54.43% |
| 31 Mar, 24 | 79 | 25.40% |
| 31 Dec, 23 | 63 | 18.87% |
| 30 Sep, 23 | 53 | 6.00% |
| 30 Jun, 23 | 50 | 28.21% |
| 31 Mar, 23 | 39 | -22.00% |
| 31 Dec, 22 | 50 | 11.11% |
| 30 Sep, 22 | 45 | -16.67% |
| 30 Jun, 22 | 54 | 35.00% |
| 31 Mar, 22 | 40 | -18.37% |
| 31 Dec, 21 | 49 | - |
| 30 Sep, 21 | 49 | -15.52% |
| 30 Jun, 21 | 58 | -40.82% |
| 31 Mar, 21 | 98 | 108.51% |
| 31 Dec, 20 | 47 | 80.77% |
| 30 Sep, 20 | 26 | -31.58% |
| 30 Jun, 20 | 38 | 8.57% |
| 31 Mar, 20 | 35 | -25.53% |
| 31 Dec, 19 | 47 | 30.56% |
| 30 Sep, 19 | 36 | -18.18% |
| 30 Jun, 19 | 44 | 15.79% |
| 31 Mar, 19 | 38 | 11.76% |
| 31 Dec, 18 | 34 | - |
| 30 Sep, 18 | 34 | 240.00% |
| 30 Jun, 18 | 10 | 11.11% |
| 31 Mar, 18 | 9 | -40.00% |
| 31 Dec, 17 | 15 | 150.00% |
| 30 Sep, 17 | 6 | 20.00% |
| 30 Jun, 17 | 5 | -28.57% |
| 31 Mar, 17 | 7 | -63.16% |
| 31 Dec, 16 | 19 | - |
36 institutional shareholders have increased their position in KALV stock as of 30 Jun 24 compared to 79 in the previous quarter (a -54.43% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | -61.11% |
| 31 Mar, 24 | 36 | 80.00% |
| 31 Dec, 23 | 20 | -23.08% |
| 30 Sep, 23 | 26 | 4.00% |
| 30 Jun, 23 | 25 | -16.67% |
| 31 Mar, 23 | 30 | 3.45% |
| 31 Dec, 22 | 29 | -6.45% |
| 30 Sep, 22 | 31 | 55.00% |
| 30 Jun, 22 | 20 | -28.57% |
| 31 Mar, 22 | 28 | 3.70% |
| 31 Dec, 21 | 27 | -15.63% |
| 30 Sep, 21 | 32 | -13.51% |
| 30 Jun, 21 | 37 | 131.25% |
| 31 Mar, 21 | 16 | -33.33% |
| 31 Dec, 20 | 24 | 20.00% |
| 30 Sep, 20 | 20 | 11.11% |
| 30 Jun, 20 | 18 | -14.29% |
| 31 Mar, 20 | 21 | 50.00% |
| 31 Dec, 19 | 14 | -26.32% |
| 30 Sep, 19 | 19 | 5.56% |
| 30 Jun, 19 | 18 | 12.50% |
| 31 Mar, 19 | 16 | 60.00% |
| 31 Dec, 18 | 10 | 25.00% |
| 30 Sep, 18 | 8 | 60.00% |
| 30 Jun, 18 | 5 | -28.57% |
| 31 Mar, 18 | 7 | 250.00% |
| 31 Dec, 17 | 2 | -33.33% |
| 30 Sep, 17 | 3 | - |
| 30 Jun, 17 | 3 | 50.00% |
| 31 Mar, 17 | 2 | - |
| 31 Dec, 16 | - | - |
14 institutional shareholders have reduced their position in KALV stock as of 30 Jun 24 compared to 36 in the previous quarter (a -61.11% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 61 | -53.79% | 12,170,426 | -74.10% | 27.92% | 0.24% | 36 | -54.43% | 14 | -61.11% |
| 31 Mar, 24 | 132 | 24.53% | 46,987,795 | 27.12% | 107.79% | 0.95% | 79 | 25.40% | 36 | 80.00% |
| 31 Dec, 23 | 106 | -4.50% | 36,964,765 | 1.93% | 106.45% | 0.97% | 63 | 18.87% | 20 | -23.08% |
| 30 Sep, 23 | 111 | 13.27% | 36,263,336 | 5.26% | 104.91% | 1.05% | 53 | 6.00% | 26 | 4.00% |
| 30 Jun, 23 | 98 | 10.11% | 34,451,525 | 2.17% | 100.11% | 1.04% | 50 | 28.21% | 25 | -16.67% |
| 31 Mar, 23 | 89 | -6.32% | 33,720,527 | -2.54% | 98.19% | 0.66% | 39 | -22.00% | 30 | 3.45% |
| 31 Dec, 22 | 95 | - | 34,599,737 | 34.95% | 122.35% | 1.13% | 50 | 11.11% | 29 | -6.45% |
| 30 Sep, 22 | 95 | 6.74% | 25,639,626 | 5.70% | 104.25% | 1.07% | 45 | -16.67% | 31 | 55.00% |
| 30 Jun, 22 | 89 | 1.14% | 24,257,176 | -0.31% | 98.78% | 1.00% | 54 | 35.00% | 20 | -28.57% |
| 31 Mar, 22 | 88 | -10.20% | 24,333,766 | 2.29% | 99.15% | 1.05% | 40 | -18.37% | 28 | 3.70% |
| 31 Dec, 21 | 98 | -10.91% | 23,787,859 | 1.84% | 97.17% | 1.06% | 49 | - | 27 | -15.63% |
| 30 Sep, 21 | 110 | -5.98% | 23,357,229 | -3.84% | 95.57% | 0.97% | 49 | -15.52% | 32 | -13.51% |
| 30 Jun, 21 | 117 | -4.88% | 24,290,978 | 3.15% | 99.43% | 0.65% | 58 | -40.82% | 37 | 131.25% |
| 31 Mar, 21 | 123 | 36.67% | 23,548,120 | 43.71% | 123.32% | 1.48% | 98 | 108.51% | 16 | -33.33% |
| 31 Dec, 20 | 90 | 47.54% | 16,385,573 | 1.14% | 91.22% | 1.11% | 47 | 80.77% | 24 | 20.00% |
| 30 Sep, 20 | 61 | -15.28% | 16,200,853 | 1.34% | 90.47% | 1.13% | 26 | -31.58% | 20 | 11.11% |
| 30 Jun, 20 | 72 | 5.88% | 15,986,874 | 2.08% | 89.57% | 1.16% | 38 | 8.57% | 18 | -14.29% |
| 31 Mar, 20 | 68 | -6.85% | 15,660,534 | 14.13% | 87.77% | 1.48% | 35 | -25.53% | 21 | 50.00% |
| 31 Dec, 19 | 73 | -3.95% | 13,721,802 | 4.08% | 76.92% | 1.41% | 47 | 30.56% | 14 | -26.32% |
| 30 Sep, 19 | 76 | 1.33% | 13,183,718 | -10.84% | 73.97% | 1.03% | 36 | -18.18% | 19 | 5.56% |
| 30 Jun, 19 | 75 | 10.29% | 14,786,498 | 6.33% | 84.55% | 1.29% | 44 | 15.79% | 18 | 12.50% |
| 31 Mar, 19 | 68 | 21.43% | 13,905,907 | 4.44% | 80.92% | 1.36% | 38 | 11.76% | 16 | 60.00% |
| 31 Dec, 18 | 56 | 19.15% | 13,315,168 | 5.33% | 77.27% | 1.10% | 34 | - | 10 | 25.00% |
| 30 Sep, 18 | 47 | 88.00% | 12,641,824 | 100.14% | 83.67% | 2.45% | 34 | 240.00% | 8 | 60.00% |
| 30 Jun, 18 | 25 | 8.70% | 6,316,414 | -2.86% | 58.49% | 1.47% | 10 | 11.11% | 5 | -28.57% |
| 31 Mar, 18 | 23 | 4.55% | 6,502,235 | 0.28% | 63.00% | 1.74% | 9 | -40.00% | 7 | 250.00% |
| 31 Dec, 17 | 22 | 46.67% | 6,483,901 | -15.96% | 60.10% | 1.01% | 15 | 150.00% | 2 | -33.33% |
| 30 Sep, 17 | 15 | -11.76% | 7,715,149 | 4.70% | 77.12% | 1.34% | 6 | 20.00% | 3 | - |
| 30 Jun, 17 | 17 | -5.56% | 7,368,643 | -2.89% | 75.86% | 1.24% | 5 | -28.57% | 3 | 50.00% |
| 31 Mar, 17 | 18 | -5.26% | 7,587,600 | 3.49% | 78.12% | 0.85% | 7 | -63.16% | 2 | - |
| 31 Dec, 16 | 19 | - | 7,331,434 | - | 95.74% | - | 19 | - | - | - |
KalVista Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of KalVista Pharmaceuticals's stock was made by Palleiko Benjamin L on Jun 10 2024, selling 15,625 shares at - per share (valued at -).
KalVista Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 7 | 20 | 35.00% |
| Q1 2024 | 36 | 36 | 100.00% |
| Q4 2023 | 8 | 22 | 36.36% |
| Q3 2023 | 12 | 23 | 52.17% |
| Q2 2023 | 6 | 15 | 40.00% |
| Q1 2023 | 11 | 19 | 57.89% |
| Q4 2022 | 9 | 10 | 90.00% |
| Q3 2022 | 3 | 12 | 25.00% |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 2 | 3 | 66.67% |
| Q4 2021 | - | 4 | - |
| Q3 2021 | 5 | 4 | 125.00% |
| Q2 2021 | 16 | 36 | 44.44% |
| Q1 2021 | 15 | 19 | 78.95% |
| Q4 2020 | 17 | 21 | 80.95% |
| Q2 2020 | - | 1 | - |
| Q1 2020 | - | 3 | - |
| Q4 2019 | 7 | 12 | 58.33% |
| Q3 2019 | 11 | 5 | 220.00% |
| Q2 2019 | 11 | 27 | 40.74% |
7 total buy trades, and 20 total sell trades (buy/sell ratio of 0.35%) were made by KalVista Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 4 | - |
| Q1 2024 | 21 | 16 | 131.25% |
| Q4 2023 | 3 | 6 | 50.00% |
| Q3 2023 | - | 6 | - |
| Q2 2023 | - | 5 | - |
| Q1 2023 | - | 5 | - |
| Q4 2022 | - | 5 | - |
| Q3 2022 | - | 6 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 1 | - |
| Q4 2021 | - | 4 | - |
| Q3 2021 | - | 4 | - |
| Q2 2021 | - | 21 | - |
| Q1 2021 | - | 18 | - |
| Q4 2020 | 2 | 19 | 10.53% |
| Q2 2020 | - | - | - |
| Q1 2020 | - | 3 | - |
| Q4 2019 | - | 8 | - |
| Q3 2019 | 10 | 4 | 250.00% |
| Q2 2019 | - | 19 | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of KalVista Pharmaceuticals's stocks.
KalVista Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| GOSS | Gossamer Bio, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| DYN | Dyne Therapeutics, Inc. |
| VRDN | Viridian Therapeutics, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| IMCR | Immunocore Holdings plc |
| COGT | Cogent Biosciences, Inc. |
| REPL | Replimune Group, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| KRON | Kronos Bio, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| MRSN | Mersana Therapeutics, Inc. |
| KURA | Kura Oncology, Inc. |
| CYTK | Cytokinetics, Incorporated |
| KRTX | Karuna Therapeutics, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
| MIRM | Mirum Pharmaceuticals, Inc. |
KALV Ownership FAQ
Who Owns KalVista Pharmaceuticals?
KalVista Pharmaceuticals is owned by institutional shareholders (27.92%), insiders (1.44%), and public (70.64%). The largest institutional shareholder of KalVista Pharmaceuticals is VR ADVISER, LLC (14.34% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (0.95% of total shares).
Who are the major institutional shareholders of KalVista Pharmaceuticals?
KalVista Pharmaceuticals's major institutional shareholders are VR ADVISER, LLC, TANG CAPITAL MANAGEMENT LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, FRAZIER LIFE SCIENCES MANAGEMENT, L.P., and CAPITAL WORLD INVESTORS. The top five shareholders own together 49.50% of the company's share outstanding.
How many KalVista Pharmaceuticals shareholders are there?
As of Jun 2024, there are 61 institutional shareholders of KalVista Pharmaceuticals.
What percentage of KalVista Pharmaceuticals is owned by VR ADVISER, LLC?
VR ADVISER, LLC owns 6.25M shares of KalVista Pharmaceuticals, representing 14.34% of the company's total shares outstanding, valued at $73.62M (as of Jun 2024).
What percentage of KalVista Pharmaceuticals is owned by TANG CAPITAL MANAGEMENT LLC?
As of Jun 2024, TANG CAPITAL MANAGEMENT LLC holds 4.22M shares of KalVista Pharmaceuticals (KALV), compromising 9.68% of the company, valued at $49.7M.
What percentage of KalVista Pharmaceuticals is owned by SUVRETTA CAPITAL MANAGEMENT, LLC?
SUVRETTA CAPITAL MANAGEMENT, LLC is the third largest holder of KalVista Pharmaceuticals. The company owns 4.19M of the company's shares outstanding (worth $49.38M).